media – Page 590 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Apple looking at easy access to your complete medical records

Chronic diseases and health conditions are often incurable and can adversely impact the longevity and quality of a person’s life if not managed actively. The wide prevalence of these conditions along with the fact that they are often preventable and frequently manageable with early detection and with the right health practices, calls for more focus on empowering patients in ongoing self-care.
- Source: Business Insider
- 717
- January 25, 2018
Apple Company Insight EHR health IT
China’s digital healthcare transformation – private hospital achieve HIMSS milestone

Explosive growth and groundbreaking digital transformations are underway in China’s enormous healthcare market, and now a Beijing hospital has become the first private healthcare organisation in the nation to achieve Stage 6 on the HIMSS EMRAM scale for its electronic medical record system.
- Source: Healthcare IT
- 538
- January 25, 2018
China health IT healthcare Market Views
Shares of biotech Juno, already up 50% on deal hopes, skyrocket on actual Celgene $9 billion offer

Celgene agreed on Monday to buy the rest of Juno Therapeutics it doesn't already own for about $9 billion in cash to gain access to Juno's pipeline of CAR-T cancer drugs.
- Source: Cnbc
- 993
- January 24, 2018
cancer CAR–T Market Views
Sanofi to acquire Bioverativ for $11.6 billion

Sanofi SA (SAN.FR) said Monday that it will acquire all outstanding shares in Bioverativ Inc. BIVV, -0.61% for $11.6 billion to expand its presence in specialty care and strengthening leadership in rare diseases.
- Source: Marketwatch
- 488
- January 24, 2018
Market Views rare diseases
The Effects Of Air Pollution On Human Health

Although it isn’t talked about often, older adults in the United States are turning to drugs and alcohol at an alarming rate. Studies have found that a large population of older Americans are suffering from substance use disorders, and the number is only expected to rise. According to research, the number of Americans aged 50 and older struggling with addiction is expected to nearly double in the coming years, going from 2.8 million to 5.7 million by 2020.
- Source: msn
- 1,085
- January 24, 2018
air pollution asthma cardiovascular pneumonia
Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C– a systematic review and meta-analysis

Direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection might pose a risk for hepatitis B virus (HBV) reactivation in patients coinfected with chronic or resolved HBV infection. The need for HBV antiviral prophylaxis during DAA treatment remains controversial. We aimed to analyse the absolute risk of HBV reactivation in patients with active or resolved HBV infection treated with DAAs for HCV infection.
- Source: Thelancet
- 512
- January 24, 2018
DAA HBV HCV Researches
Can digital tools really change patient behavior?

Using the virtual reality (VR) platform, doctors can show patients, in an immersive, highly detailed way, what will happen to their bodies if they take their medication, stop smoking, and eat better — and what will happen if they don't.
- Source: MM&M
- 801
- January 24, 2018
digital health medical device Virtual Reality wearables
‘Explosive evolution’ of techniques to restore blood flow to the brain

Recent decades have seen an "explosive evolution" of techniques to restore blood flow to areas of the brain endangered by stroke or clogged arteries, according to a report by Loyola Medicine neurologists and neurosurgeons.
- Source: Science Daily
- 682
- January 24, 2018
brain medical device Researches stroke surgery
Leaf Healthcare touts reduced pressure injuries in Leaf wearable sensor study

Patient monitoring system developer Leaf Healthcare today released results from a study exploring the ability of its Leaf wearable patient sensor to prevent pressure injuries on acutely ill adults, touting that patients were 73% less likely to develop such injuries when monitored with the device.
- Source: Mass Device
- 621
- January 24, 2018
medical device Researches wearables
Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars

Sandoz, a Novartis division and the global leader in biosimilars, announced a global partnership with Asia’s premier biopharmaceuticals company, Biocon, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.
- Source: Sandoz
- 620
- January 23, 2018
biosimilars immunology Market Views oncology

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.